The world was plunged into a fight against Covid-19, prompting scientists to seek efficient treatment methods. Among the potential remedies, ivermectin, known for its potent antiparasitic properties, began to gain attention. The intrigue around this drug stems from the speculation regarding its antiviral abilities. If found to be effective against Covid-19, it would pave a new path for treatment. Initial studies suggest that ivermectin might hinder viral replication - a critical function that allows the virus to overpower the host's immune system. It is also postulated that ivermectin might prevent the virus from entering cells - a fundamental stage of its lifecycle. Even with these promising insights, the scientific community continues to stress the importance of thorough research to confirm these hypotheses within the Covid-19 framework. The exploration of ivermectin's usefulness against this novel virus underlines the dynamic character of medical research where known drugs can be repurposed. Nevertheless, it's crucial to maintain scientific rigor, ensuring claims of its effectiveness are based on robust evidence. Therefore, while ivermectin's transition from treating parasites to possibly battling a pandemic is indeed captivating, it also highlights the larger necessity for meticulous studies to affirm its value in this uncharted territory.